Key result
In spontaneously hypertensive rats, STZ-induced diabetic hyperglycemia attenuated central Ang-(1-7) levels and downregulated the Ang-(1-7)-Mas-R-nNOS pathway.
Why the study?
Does diabetic hyperglycemia alter central Ang-(1-7)-Mas-R-nNOS pathways and blood pressure in spontaneously hypertensive rats?
Does diabetic hyperglycemia alter central Ang-(1-7)-Mas-R-nNOS pathways and blood pressure in spontaneously hypertensive rats?
Diabetic hyperglycemia downregulates the central Ang-(1-7)-Mas-R-nNOS pathway in spontaneously hypertensive rats, and enhancing this system or blocking oxidative stress improves systolic blood pressure.
Answers are grounded in this paper and cite their sources.
Central Ang-(1-7) pathway may modulate hypertension with hyperglycemia in rats; leaves open human stroke relevance.
BACKGROUND/AIMS: Hypertension is a major cause of stroke, and diabetes can increase incidence of this disease. We determined the role played by central angiotensin-(1-7) [Ang-(1-7)] pathway in modulating spontaneously hypertension with diabetic hyperglycemia. METHODS: Western Blot analysis and ELISA were used to determine the protein expression of Ang-(1-7) and its signal pathway Mas-R-nNOS in the cerebral cortex and hippocampus of spontaneously hypertensive rats (SHR) and control animals. In a subset of animals, diabetic hyperglycemia was induced by systemic injection of streptozotocin (STZ). We analyzed a relationship between the levels of central Ang-(1-7) and plasma brain natriuretic peptide (BNP) indicating a risk of ischemic stroke. We further examined the effects of Ang-(1-7) on arterial blood pressure. RESULTS: Our findings demonstrated for the first time that administration of STZ 1) attenuates the levels of Ang-(1-7) in the cerebral cortex and hippocampus, which are closely linked to plasma BNP; and 2) leads to downregulation of central Ang-(1-7)-Mas-R-nNOS pathways. Notably, STZ has greater effects in SHR. Additionally, inhibition of oxidative stress can largely improve downregulation of Ang-(1-7) in diabetic SHR. Moreover, central stimulation of Ang-(1-7) pathway or a blockade of oxidative stress improves systolic blood pressure in diabetic SHR. CONCLUSIONS: The Ang-(1-7) signaling pathway is engaged in the adaptive mechanisms associated with diabetic hypertension, suggesting that enhancing Ang-(1-7)-Mas-R-nNOS system is likely to be beneficial in preventing against cardiovascular and cerebrovascular dysfunction and vulnerability related to spontaneously hypertension, particularly to diabetic hypertension.
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) studied Hypertension and diabetic hyperglycemia. Streptozotocin (STZ) induced diabetic hyperglycemia vs. Control animals / non-diabetic SHR was evaluated on Protein expression of Ang-(1-7) and its signal pathway Mas-R-nNOS in the cerebral cortex and hippocampus, and arterial blood pressure. In spontaneously hypertensive rats, STZ-induced diabetic hyperglycemia attenuated central Ang-(1-7) levels and downregulated the Ang-(1-7)-Mas-R-nNOS pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: